Sugi Predict

Sugi Predict / Compounds / SCHEMBL573358

SCHEMBL573358

SCHEMBL573358

O=[N+]([O-])c1cc(C(F)(F)F)cnc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.51
▸ CYP3A4 P08684 3/20 0.51
▸ TDP1 Q9NUW8 3/20 0.51
▸ TSHR P16473 2/20 0.51
▸ HPGD P15428 1/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ HIF1A Q16665 1/20 0.51
▸ TXNRD1 Q16881 1/20 0.51
▸ TXNRD3 Q86VQ6 1/20 0.51
▸ TXNRD2 Q9NNW7 1/20 0.51
▸ FGFR4 P22455 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ PTPN5 P54829 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ GPR35 Q9HC97 1/20 0.43
▸ MAPT P10636 7/20 0.43
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ GAA P10253 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17477195 0.87 POLB (0.41) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL11188525 0.81 ALDH1A1 (0.53) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL18665461 0.81 ALDH1A1 (0.53) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL572768 0.79 CYP3A4 (0.51) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL572669 0.79 TDP1 (0.61) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL10280706 0.79 ALDH1A1 (0.51) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL29439786 0.79 TDP1 (0.61) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL30358860 0.79 CYP3A4 (0.51) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL2371582 0.79 ALDH1A1 (0.51) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL30788051 0.79 ALDH1A1 (0.51) ALDH1A1CYP3A4TDP1TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118619852-A Ligand-promotion-based tyrosine compound olefination reaction method 浙江工业大学 2024-09-10 — — CN claimed
CN-118620023-A Ligand-promotion-based tyrosine compound cyclization method 浙江工业大学 2024-09-10 — — CN claimed
CN-118459299-A Gamma site deuteration method of fatty amine compound 浙大宁波理工学院 2024-08-09 — — CN claimed
CN-118271259-A Organic single-molecule white light material based on 1,3, 5-triphenoxazine/thia/selenazine arene olefination 重庆大学 2024-07-02 — — CN claimed
CN-118146185-A Palladium-catalyzed synthesis of isocoumarin derivative containing aldehyde group and synthesis method 江苏师范大学 2024-06-07 — — CN claimed
US-20170218007-A1 A PROCESS FOR THE PREPARATION OF NUCLEOSIDE PHOSPHORAMIDATE LUPIN LIMITED (IN) 2017-08-03 — — US claimed
US-20260103464-A1 CYCLOPROPYL-(HETERO)ARYL-SUBSTITUTED ETHYLSULPHONYL-PYRIDINE DERIVATIVES BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2026-04-16 — — US disclosed
US-12435083-B2 Cyclopropyl-(hetero)aryl-substituted ethylsulphonyl-pyridine derivatives BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2025-10-07 — — US disclosed
CN-119742448-A High-voltage additive for lithium battery electrolyte, electrolyte and lithium ion battery 中国科学院宁波材料技术与工程研究所 2025-04-01 — — CN disclosed
CN-118619852-A Ligand-promotion-based tyrosine compound olefination reaction method 浙江工业大学 2024-09-10 — — CN disclosed
CN-118620023-A Ligand-promotion-based tyrosine compound cyclization method 浙江工业大学 2024-09-10 — — CN disclosed
CN-118620023-A Ligand-promotion-based tyrosine compound cyclization method 浙江工业大学 2024-09-10 — — CN disclosed
CN-118525021-A MALT 1-targeted proteolytic compounds 上海齐鲁制药研究中心有限公司 2024-08-20 — — CN disclosed
CN-1374952-A Benzimidazolone derivatives and their use as phosphodiesterase inhibibors FUJISAWA PHARMACEUTICAL CO (JP) 2002-10-16 — — CN disclosed
US-6448290-B1 PROSTAGLANDIN E2 ANTAGONIST OR AGONIST; INHIBITION OF UTERINE CONTRACTION, ANALGESICS, ANTIDIARRHEALS, SLEEP INDUCERS, INCREASING VESICAL CAPACITY, CATHARTIC, SUPPRESSION OF GASTRIC ACID SECRETION, ANTIHYPERTENSIVE, DIURETIC AGENTS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-09-10 — — US disclosed
EP-1196391-A1 BENZIMIDAZOLONE DERIVATIVES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-17 — — EP disclosed
WO-2001005770-A1 BENZIMIDAZOLONE DERIVATIVES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-25 — — WO disclosed
EP-0947500-A1 SULFONAMIDE AND CARBOXAMIDE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 1999-10-06 — — EP disclosed
US-5811432-A Azaoxindole derivatives PFIZER INC (US) 1998-09-22 — — US disclosed
EP-0436333-A2 Azaoxindole derivatives PFIZER INC. (US) 1991-07-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170218007-A1 A PROCESS FOR THE PREPARATION OF NUCLEOSIDE PHOSPHORAMIDATE SAMHD1, PNP, MTAP ALDH1A1 2758/4885CYP3A4 135/4885TDP1 1455/4885
US-12435083-B2 Cyclopropyl-(hetero)aryl-substituted ethylsulphonyl-pyridine derivatives CYCS, CYP2E1, CYP1A1 ALDH1A1 512/4885CYP3A4 19/4885TDP1 4126/4885
US-20260103464-A1 CYCLOPROPYL-(HETERO)ARYL-SUBSTITUTED ETHYLSULPHONYL-PYRIDINE DERIVATIVES CBR3, CYCS, CBR1 ALDH1A1 2267/4885CYP3A4 331/4885TDP1 4527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.